metaLead Therapeutics ApS

CVR 44212765 · Private limited company (ApS) · Active · Low risk

metaLead Therapeutics ApS is a Private limited company (ApS), founded on , based in Taastrup. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 2 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK -4.1m and a net result of DKK -1.4m.

Bankruptcy risk for metaLead Therapeutics ApS

0.6%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 66% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time at current address1 yrs · bankruptcy rate 14.0%1.6×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Qualification / emphasis of matterNo · bankruptcy rate 7.1%0.80×
Missed filing deadlines0 · bankruptcy rate 7.1%0.81×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44212765
Status
Active
Company type
Private limited company (ApS)
Founded
(3 years)
Address
c/o RSM Danmark, Kingosvej 3
2630 Taastrup
Municipality
Høje-Taastrup
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 40k
Auditor
RSM Danmark, Statsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 2
Missing annual reportNo
Negative equityYes
Equity ratio-1,229.4%
Current ratio1,573%
Moves (last 2 years)1
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address4
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -1.1mDKK -2.0m
Net profitDKK -1.4mDKK -2.8m
EquityDKK -4.1mDKK -2.8m
Total assetsDKK 336kDKK 1.6m
CashDKK 335kDKK 1.6m
Short-term debtDKK 21kDKK 129k
Avg. employees11

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · RSM Danmark, Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025114
2 Aug 2023 – 31 Dec 2024113

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOEmilie Déjean
Owner (100%)metaLead Therapeutics AGCurrent
FounderMichal Mazal ShoshanCurrent
FounderEmilie DéjeanCurrent

Address history (1 moves)

c/o RSM Danmark, Kingosvej 3, 2630 Taastrup
c/o BioInnovation Institute, Ole Maaløes Vej 5, 3., 2200 København N

Other companies at the same address

Similar companies in Høje-Taastrup

Questions and answers about metaLead Therapeutics ApS

Has metaLead Therapeutics ApS gone bankrupt?

No, metaLead Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of metaLead Therapeutics ApS?

Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the auditor of metaLead Therapeutics ApS?

metaLead Therapeutics ApS most recently used RSM Danmark, Statsautoriseret Revisionspartnerselskab.

When was metaLead Therapeutics ApS founded?

metaLead Therapeutics ApS was founded on 2 August 2023.

What is the equity of metaLead Therapeutics ApS?

Equity was DKK -4.1m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.